Goldman Sachs Group Inc Tandem Diabetes Care Inc Call Options Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$35.21 - $47.3 $957,712 - $1.29 Million
27,200 New
27,200 $1.15 Million
Q2 2022

May 14, 2024
BUY
$53.22 - $123.09 $1.41 Million - $3.26 Million
26,500 New
26,500 $1.57 Million
Q1 2022

May 16, 2022
BUY
$101.89 - $150.09 $2.7 Million - $3.98 Million
26,500 New
26,500 $3.08 Million

Others Institutions Holding TNDM

# of Institutions
361
Shares Held
72.5M
Call Options Held
3.36M
Put Options Held
229K
View Full List

About TANDEM DIABETES CARE INC

TNDM Quotes by TradingView
  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.14B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email